NEW YORK (GenomeWeb News) - Waters said today that XenoTech, a contract research organization based in Lenexa, Kan., has purchased a Waters Synapt High Definition Mass Spectrometry system.

XenoTech is using the system to provide metabolite profiling services, Waters said.

The CRO is using the Synapt, in combination with a Waters Acquity UltraPerformance Liquid Chromatograph, to provide its clients with in vitro drug metabolism study data.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.